"This is the first step towards personalized treatment of diabetes,” Goop explained in a statement. "Current diagnostics and classification of diabetes are insufficient and unable to predict future complications or choice of treatment."
Victoria Salem, a consultant and clinical scientist at Imperial College London who was not involved in the study, agrees. "This is definitely the future of how we think about diabetes as a disease," she said in an interview with the BBC.
But she added, much more research was needed to explore these findings further. "There is still a massively unknown quantity – it may well be that worldwide there are 500 subgroups depending on genetic and local environment effects.”
The next step will be to embark on similar programs with people of different ethnic backgrounds. The researchers are already planning studies in China and India.